In vitro assay for inhibitors of the intron self-splicing reaction in Pneumocystis carinii
AssigneeUniversity of Medicine & Dentistry of NJ
InventorsMichael J. Leibowitz, Yong Liu
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of Medicine & Dentistry of NJ
InventorsMichael J. Leibowitz, Yong Liu
Estimating the term…
The present invention pertains to an in vitro method for assaying for an inhibitor of the catalytic Group I self-splicing intron reaction in the nuclear rRNA genes of Pheumocystis carinii which comprises the steps of (a) providing a DNA template containing the intron (I) from the 26S rRNA gene in Pneumocystis carinii and a portion of the 5' and 3' flanking exons (E1 and E2, respectively) between nucleotides 1963 and 2267 of 26S rRNA (660 nucleotides of amplified rRNA gene including the group I intron); (b) preparing an RNA precursor by transcription of the DNA template in the presence of labeled nucleoside triphosphates to produce a labeled RNA precursor (E1-I-E2); (c) purifying the RNA precursor; (d) incubating the RNA precursor and the inhibitor in the presence of guanosine triphosphate and magnesium ions; and (e) determining the degree of inhibition by the inhibitor on the intron splicing reaction in the RNA precursor by measuring the amount of labeled splicing intermediates and splicing products.
An in vitro method for assaying for an inhibitor of the catalytic Group I self-splicing intron reaction in the nuclear rRNA genes of Pneumocystis carinii which comprises the steps of:
An in vitro method for assaying for an inhibitor of the catalytic Group I self-splicing intron reaction in the nuclear rRNA genes of Pneumocystis carinii which comprises the steps of:
The method according to claim 14, wherein the two oligodeoxyribonucleotide primers are 4208 (5'-ATTTAGGTGACACTATAGAAGCTATTGGACCAGACGGGAAC-3') (SEQ ID NO:33), in which the first 17 nucleotides are a bacteriophage SP6 promoter, and 4358 (5'-GACGAGGCATTTGGCTACC-3') (SEQ ID NO:34) to amplify the region between nucleotides 1963 and 2267 of 26S rRNA.
The method according to claim 14, wherein the two oligodeoxyribonucleotide primers are 4208 (5'-ATTTAGGTGACACTATAGAAGCTATTGGACCAGACGGGAAC-3') (SEQ ID NO:33) and 3734 (5'-GGGTGAACAATCCAACGCTTACCG-3') (SEQ ID NO:35) to amplify the region between nucleotides 1963 and 2903 of 26S rRNA.
Dependencies are inferred from the claim text.